China (Mainland)
Premiumsupplier
Fulvestrant 129453-61-8 CAS NO.129453-61-8
- Min.Order: 100 Metric Ton
- Payment Terms: L/C,T/T,MoneyGram,Other
- Product Details
Keywords
- 129453-61-8
- Fulvestrant 129453-61-8 seller in China
- Fulvestrant 129453-61-8 factory in China
Quick Details
- ProName: Fulvestrant 129453-61-8
- CasNo: 129453-61-8
- Molecular Formula: C32H47F5O3S
- Appearance: white powder/crystal
- Application: Used for research and industrial manuf...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100kg/Month Metric Ton/Day
- Purity: 98%min
- Storage: Store in a cool,dry place and keep awa...
- Transportation: Common products:Sea/Air/Courier Dange...
- LimitNum: 100 Metric Ton
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
Fulvestrant//CAS No.:129453-61-8
1.Base Date
Name:Fulvestrant
CAS No.:129453-61-8
Molecular formular:C32H47F5O3S
Fulvestrant Chemical structure:
2. Details of Fulvestrant
Superlist Name:Fulvestrant
Molecular Formula:C32H47F5O3S
CAS No.:129453-61-8
Purity:99%
Synonyms:Fulvestrant;(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
Molecular Weight:606.77
3.Description of Fulvestrant
Fulvestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer inpostmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
